Allergan (AGN) Tops Q2 EPS by 29c, Offers FY and Q3 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Wall St subdued in choppy trade after big bank earnings, chips slide
- Oil prices ease as US-Russia diesel deal hopes offset Middle East attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- CoreWeave stock drops on insider selling notice
- Sysco calls on Teamsters to end LA strike after economic deal reached
Allergan Reports Strong Second Quarter 2018 Results Including GAAP Net Revenues of $4.1 Billion
July 26, 2018 6:31 AM EDTDUBLIN, July 26, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today reported its second quarter 2018 performance. Total second quarter 2018 GAAP net revenues were $4.12 billion, a 2.9 percent increase from the prior year quarter.
SECOND QUARTER 2018
 (unaudited; $ in millions, except per share amounts)
Q2 '18
Q2 '17
Q2 '18 v Q2 '17
Six
Months
Ended
June 30,
... More


